TY - JOUR
T1 - The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure
AU - Martin-Loeches, Ignacio
AU - Muriel-Bombín, Arturo
AU - Ferrer, Ricard
AU - Artigas, Antonio
AU - Sole-Violan, Jordi
AU - Lorente, Leonardo
AU - Andaluz-Ojeda, David
AU - Prina-Mello, Adriele
AU - Herrán-Monge, Ruben
AU - Suberviola, Borja
AU - Rodriguez-Fernandez, Ana
AU - Merino, Pedro
AU - Loza, Ana M.
AU - Garcia-Olivares, Pablo
AU - Anton, Eduardo
AU - Tamayo, Eduardo
AU - Trapiello, Wysali
AU - Blanco, Jesús
AU - Bermejo-Martin, Jesús F.
AU - García-García, Marta María
AU - Pueyo, Mª Jesús López
AU - Ratero, Jose Antonio Fernandez
AU - Barrios, Miguel Martinez
AU - Torre, Fernando Callejo
AU - Echeverri, Sergio Ossa
AU - Ule, Demetrio Carriedo
AU - Berrot, Ana Mª Domínguez
AU - Domínguez, Fco Javier Díaz
AU - Moradillo, Susana
AU - Martínez, Braulio Alvarez
AU - Albalá, Noelia
AU - Ballesteros, Juan Carlos
AU - Perez, Marta Paz
AU - Losada, Elena Perez
AU - Macías, Santiago
AU - García, Rafael Pajares
AU - Cervigón, Noelia Recio García
AU - Serrano, Mª Mar Gobernado
AU - Calavia, Mª José Fernández
AU - Torres, Daniel Moreno
AU - Tarancón, Concha
AU - Loreto, Teresa
AU - Carcelen, Priscila
AU - Gandía, Rafael Cítores y.Francisco
PY - 2017/12/1
Y1 - 2017/12/1
N2 - © 2017, The Author(s). Background: Pre-evaluation of endogenous immunoglobulin levels is a potential strategy to improve the results of intravenous immunoglobulins in sepsis, but more work has to be done to identify those patients who could benefit the most from this treatment. The objective of this study was to evaluate the impact of endogenous immunoglobulins on the mortality risk in sepsis depending on disease severity. Methods: This was a retrospective observational study including 278 patients admitted to the ICU with sepsis fulfilling the SEPSIS-3 criteria, coming from the Spanish GRECIA and ABISS-EDUSEPSIS cohorts. Patients were distributed into two groups depending on their Sequential Organ Failure Assessment score at ICU admission (SOFA < 8, n = 122 and SOFA ≥ 8, n = 156), and the association between immunoglobulin levels at ICU admission with mortality was studied in each group by Kaplan–Meier and multivariate logistic regression analysis. Results: ICU/hospital mortality in the SOFA < 8 group was 14.8/23.0%, compared to 30.1/35.3% in the SOFA ≥ 8 group. In the group with SOFA < 8, the simultaneous presence of total IgG < 407 mg/dl, IgM < 43 mg/dl and IgA < 219 mg/dl was associated with a reduction in the survival mean time of 6.6 days in the first 28 days and was a robust predictor of mortality risk either during the acute or during the post-acute phase of the disease (OR for ICU mortality: 13.79; OR for hospital mortality: 7.98). This predictive ability remained in the absence of prior immunosuppression (OR for ICU mortality: 17.53; OR for hospital mortality: 5.63). Total IgG < 407 mg/dl or IgG1 < 332 mg/dl was also an independent predictor of ICU mortality in this group. In contrast, in the SOFA ≥ 8 group, we found no immunoglobulin thresholds associated with neither ICU nor hospital mortality. Conclusions: Endogenous immunoglobulin levels may have a different impact on the mortality risk of sepsis patients based on their severity. In patients with moderate organ failure, the simultaneous presence of low levels of IgG, IgA and IgM was a consistent predictor of both acute and post-acute mortalities.
AB - © 2017, The Author(s). Background: Pre-evaluation of endogenous immunoglobulin levels is a potential strategy to improve the results of intravenous immunoglobulins in sepsis, but more work has to be done to identify those patients who could benefit the most from this treatment. The objective of this study was to evaluate the impact of endogenous immunoglobulins on the mortality risk in sepsis depending on disease severity. Methods: This was a retrospective observational study including 278 patients admitted to the ICU with sepsis fulfilling the SEPSIS-3 criteria, coming from the Spanish GRECIA and ABISS-EDUSEPSIS cohorts. Patients were distributed into two groups depending on their Sequential Organ Failure Assessment score at ICU admission (SOFA < 8, n = 122 and SOFA ≥ 8, n = 156), and the association between immunoglobulin levels at ICU admission with mortality was studied in each group by Kaplan–Meier and multivariate logistic regression analysis. Results: ICU/hospital mortality in the SOFA < 8 group was 14.8/23.0%, compared to 30.1/35.3% in the SOFA ≥ 8 group. In the group with SOFA < 8, the simultaneous presence of total IgG < 407 mg/dl, IgM < 43 mg/dl and IgA < 219 mg/dl was associated with a reduction in the survival mean time of 6.6 days in the first 28 days and was a robust predictor of mortality risk either during the acute or during the post-acute phase of the disease (OR for ICU mortality: 13.79; OR for hospital mortality: 7.98). This predictive ability remained in the absence of prior immunosuppression (OR for ICU mortality: 17.53; OR for hospital mortality: 5.63). Total IgG < 407 mg/dl or IgG1 < 332 mg/dl was also an independent predictor of ICU mortality in this group. In contrast, in the SOFA ≥ 8 group, we found no immunoglobulin thresholds associated with neither ICU nor hospital mortality. Conclusions: Endogenous immunoglobulin levels may have a different impact on the mortality risk of sepsis patients based on their severity. In patients with moderate organ failure, the simultaneous presence of low levels of IgG, IgA and IgM was a consistent predictor of both acute and post-acute mortalities.
KW - Immunoglobulins
KW - Sepsis
KW - Severity
KW - Survival
UR - https://www.scopus.com/pages/publications/85018503351
U2 - 10.1186/s13613-017-0268-3
DO - 10.1186/s13613-017-0268-3
M3 - Article
SN - 2110-5820
VL - 7
JO - Annals of intensive care
JF - Annals of intensive care
IS - 1
M1 - 44
ER -